🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Intrahepatic Bile Duct Cancer

Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study NCT07640048n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Adebrelimab, Gemcitabine, Cisplatin, S-1, Apatinib Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery NCT04891289Phase 211 sites📍 Bethesda📍 St Louis📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: Gemcitabine, Oxaliplatin, Dexamethasone, Floxuridine (FUDR), Implanted Medical Device REGULUS: MRI-guided Adaptive SABR for Liver Cancers NCT07223307Phase 21 site📍 Palo Alto Stanford University · Tests: MRI-guided adaptive stereotactic ablative body radiotherapy (SABR) Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma NCT07780838Phase 21 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab, Gemcitabine Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer NCT03942328Phase 1, Phase 21 site📍 Rochester Mayo Clinic · Tests: Atezolizumab, Bevacizumab, External Beam Radiation Therapy, Pheresis, Pneumococcal 13-valent Conjugate Vaccine Liver Transplantation in Intrahepatic Cholangiocarcinoma NCT06140134n/a2 sites📍 Newark📍 Newark Rutgers, The State University of New Jersey · Tests: Liver Transplant Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer NCT06280508Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Adebrelimab, Apatinib, Gemcitabine, cisplatin Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer NCT07614061Phase 11 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy NCT06375915Phase 24 sites📍 Bergamo📍 Milan📍 Naples Francesco De Cobelli · Tests: radioembolization with Y-90, Durvalumab, Cisplatin, Gemcitabine Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis NCT06781242n/a2 sites📍 Bologna📍 Modena IRCCS Azienda Ospedaliero-Universitaria di Bologna Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma NCT06956716Phase 1, Phase 21 site📍 Hangzhou Zhejiang University · Tests: individualized anti-tumor new antigen iNeo-Vac-R01 injection, Gemcitabine + cisplatin (GP), Sintilimab injection Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments NCT06862934n/a1 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence NCT05557578Phase 22 sites📍 Hangzhou📍 Hanzhou Zhejiang Cancer Hospital · Tests: Tislelizumab combined with GEMOX (GOT) regimen Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury NCT07760038NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Phycocyanin, Maltodextrin Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial) NCT06859684Phase 21 site📍 Chengdu West China Hospital · Tests: Durvalumab, hepatic arterial infusion chemotherapy (HAIC), Lenvatinib A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma NCT05967182Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Pembrolizumab, Gemcitabine, Cisplatin An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer. NCT07101237n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Multi-modal ultrasonic imaging system for liver cancer Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) NCT06101277NA1 site📍 Sacramento University of California, Davis · Tests: Ablative local therapy HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma NCT06858735Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Durvalumab, Gemcitabine, Cisplatin A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma NCT07063888Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Adjuvant Concurrent Chemoradiotherapy with Simultaneous Integrated Boost Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma NCT04078230NA13 sites📍 Baltimore📍 Beijing📍 Beijing Second Affiliated Hospital, Zhejiang University, School of … · Tests: Extend LymphAdenectomy TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma NCT04954781Phase 21 site📍 Shanghai Fudan University · Tests: Tislelizumab, TACE Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extra- and Intrahepatic Cholangiocarcinoma NCT06440993Phase 212 sites📍 Aachen📍 Bonn📍 Cologne Institut für Klinische Krebsforschung IKF GmbH at Krankenha… · Tests: Gemcitabine, Cisplatin, Durvalumab, ID-RFA Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma NCT07766187Phase 21 site📍 Madison University of Wisconsin, Madison · Tests: Histotripsy, Durvalumab, Biopsy Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers NCT07337850n/a1 site📍 Mumbai Tata Memorial Centre · Tests: gallium-68-Fibroblast Activation Protein Inhibitor Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection NCT06406816EARLY Phase 11 site📍 Fuzhou Yongyi Zeng · Tests: Neoantigen Vaccine plus Capecitabine Scout Dose of Resin Microspheres NCT07476651NA1 site📍 Seoul Seoul National University Hospital · Tests: scout dose Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma NCT06058663Phase 11 site📍 Jacksonville Mayo Clinic · Tests: Angiography, Biopsy, Biospecimen Collection, Computed Tomography, Durvalumab Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio NCT05655949Phase 21 site📍 Boston Beth Israel Deaconess Medical Center · Tests: Gemcitabine, Cisplatin, Durvalumab, Yttrium-90
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy